Agilent | A

Stock Price
128.75
Daily Change
0.27 0.21%
Monthly
13.71%
Yearly
-6.04%
Q3 Forecast
127.68

Peers Price Chg Day Year Date
Agilent 128.75 0.27 0.21% -6.04% Sep/05
Abbott 132.94 0.13 0.10% 16.68% Sep/05
Align Technology 139.12 4.42 3.28% -37.08% Sep/05
Bio-Rad Laboratories 295.43 6.00 2.07% -10.48% Sep/05
Bruker 30.83 1.04 3.49% -51.84% Sep/05
Charles River Laboratories 163.99 1.68 1.04% -12.63% Sep/05
Quest Diagnostics 183.49 3.38 1.88% 20.12% Sep/05
Danaher 200.21 1.18 0.59% -24.77% Sep/05
Edwards Lifesciences 80.94 -0.02 -0.02% 21.19% Sep/05
Exact Sciences 53.81 2.40 4.67% -8.97% Sep/05
Hologic 66.76 0.37 0.56% -18.16% Sep/05
Henry Schein 69.43 1.65 2.43% 0.90% Sep/05
Illumina 98.93 1.25 1.28% -20.47% Sep/05
IQVIA Holdings 187.68 3.60 1.96% -22.83% Sep/05
Intuitive Surgical 466.86 12.34 2.72% -1.06% Sep/05
Laboratory Of America 278.67 3.44 1.25% 24.30% Sep/05
Mettler Toledo International 1,305.71 17.92 1.39% -5.26% Sep/05
Myriad Genetics 6.61 -0.18 -2.65% -75.49% Sep/05
Revvity 86.64 0.94 1.10% -24.90% Sep/05
Quidel 28.68 0.89 3.20% -33.99% Sep/05
Repligen 124.56 3.98 3.30% -15.31% Sep/05
Roche Holding 274.20 -1.50 -0.54% 2.62% Sep/06
Bio Techne 54.41 1.49 2.82% -24.00% Sep/05
Thermo Fisher Scientific 492.60 3.11 0.64% -19.59% Sep/05
Waters 306.32 6.63 2.21% -6.72% Sep/05
Dentsply International 14.62 0.29 2.02% -42.75% Sep/05
Zimmer Biomet Holdings 105.73 0.97 0.93% 0.76% Sep/05

Indexes Price Day Year Date
US500 6481 -20.59 -0.32% 19.84% Sep/05

Agilent traded at $128.75 this Friday September 5th, increasing $0.27 or 0.21 percent since the previous trading session. Looking back, over the last four weeks, Agilent gained 13.71 percent. Over the last 12 months, its price fell by 6.04 percent. Looking ahead, we forecast Agilent to be priced at 127.68 by the end of this quarter and at 124.53 in one year, according to Trading Economics global macro models projections and analysts expectations.

Agilent Technologies, Inc. provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company serves the life sciences, diagnostics and applied chemical markets. The Company’s business segments include life sciences and applied markets business, diagnostics and genomics business, and Agilent CrossLab business. The life sciences and applied markets business segment provides application-focused solutions that include instruments and software. The Company's diagnostics and genomics business segment includes the genomics, nucleic acid contract manufacturing and research and development, pathology, companion diagnostics, reagent partnership and biomolecular analysis businesses. The Company's Agilent CrossLab business segment spans the entire lab with its consumables and services portfolio.